Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Viruses|September 27, 2025
The Use of Nonhuman Primate Models for Advancing HIV PrEPElena Bekerman, Christian CallebautJournal of Medical Virology|May 15, 2023
Antiviral activity of tenofovir alafenamide (TAF) against HIV-1 clinical isolates harboring K65RStephanie Cox, Nicolas Margot, Christian CallebautAntimicrobial Agents and Chemotherapy|December 8, 2020
Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug ClassesNicolas Margot, Renee Ram, Martin Rhee, et al.AIDS Research and Human Retroviruses|April 6, 2018
Antiviral Activity of Tenofovir Alafenamide Against HIV-1 Subtypes and Emergence of K65RStephanie Cox, Nicolas Margot, Michael Miller, et al.Journal of Medical Virology|December 15, 2018
Development of an HIV-1 integrase genotyping assay for HIV-1 subtype AEYang Liu, Nicolas Margot, Kathryn M Kitrinos, et al.Antimicrobial Agents and Chemotherapy|July 8, 2015
In Vitro Virology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil FumarateChristian Callebaut, George Stepan, Yang Tian, et al.Antimicrobial Agents and Chemotherapy|July 8, 2015
Characterization of HIV-1 Resistance to Tenofovir Alafenamide In VitroNicolas A Margot, Audun Johnson, Michael D Miller, et al.Journal of Medical Virology|April 14, 2025
Phenotypic Characterization of Replication-Impaired Lenacapavir-Resistant HIV Clinical IsolatesSally Demirdjian, Vidula Naik, Nicolas Margot, et al.Current Opinion in HIV and AIDS|December 6, 2021
Lenacapavir: a first-in-class HIV-1 capsid inhibitorHadas Dvory-Sobol, Naveed Shaik, Christian Callebaut, et al.Antimicrobial Agents and Chemotherapy|January 29, 2020
Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184VNicolas Margot, Renee Ram, Michael Abram, et al.Pageof 8